Seegene Unveils COVID Testing Initiative to Help End Pandemic
Seegene unveiled a global initiative for preemptive and routine PCR COVID-19 testing to help individuals stay healthy during the pandemic.
Read MorePosted by Andy Lundin | May 26, 2022 | Covid 19, Immunoassay Reagents & test Kits |
Seegene unveiled a global initiative for preemptive and routine PCR COVID-19 testing to help individuals stay healthy during the pandemic.
Read MorePosted by Chris Wolski | May 26, 2022 | Cancer |
Liquid biopsy is proving itself as both an efficacious and cost-effective way to provide a cancer diagnosis to patients.
Read MorePosted by Andy Lundin | May 24, 2022 | Diabetes & Metabolic Diseases |
The American Liver Foundation announced a screening and public awareness campaign to test for fatty liver disease over the next five years.
Read MorePosted by Chris Wolski | May 20, 2022 | Covid 19, Emerging & Zoonotic Diseases |
A clear set of pandemic prevention and preparedness strategies will be critical for clinical labs to meet the challenges the next event.
Read MorePosted by Andy Lundin | May 17, 2022 | Unknown Origin & Other Cancer Types |
The biomarkers can predict a patient’s response to immunotherapy and the adverse events they may experience from the same immunotherapy.
Read More